Comparing PI3K/Akt Inhibitors Used in Ovarian Cancer Treatment

Epithelial ovarian carcinoma (EOC) is the most lethal gynecological malignancy. Herein, we sought to determine the efficacy of phosphoinositide 3-kinase (PI3K)/Akt inhibition using three AZD compounds in a NOD-SCID xenograft mouse model and Akt regulation in a panel of eight ovarian cancer cell line...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yi-Hui, Huang, Yu-Fang, Chen, Chien-Chin, Huang, Chia-Yen, Chou, Cheng-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063971/
https://www.ncbi.nlm.nih.gov/pubmed/32194423
http://dx.doi.org/10.3389/fphar.2020.00206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063971/
https://www.ncbi.nlm.nih.gov/pubmed/32194423
http://dx.doi.org/10.3389/fphar.2020.00206

Ejemplares similares